Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA-Reference-Cited by-同舟云学术

Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA

Published:2017-05-12 Issue:9 Volume:56 Page:1498-1509
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:

Author:

van der Heijde Désirée¹,Dougados Maxime²,Landewé Robert³⁴,Sieper Joachim⁵,Maksymowych Walter P.⁶,Rudwaleit Martin⁷,Van den Bosch Filip⁸,Braun Jürgen⁹,Mease Philip J.¹⁰,Kivitz Alan J.¹¹,Walsh Jessica¹²,Davies Owen¹³,Bauer Lars¹⁴,Hoepken Bengt¹⁵,Peterson Luke¹⁵,Deodhar Atul¹⁶

Affiliation:

1. Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands

2. Department of Rheumatology, Cochin Hospital, Paris, France

3. Clinical Immunology and Rheumatology, Academic Medical Center, Amsterdam

4. Department of Rheumatology, Zuyderland Medical Center, Heerlen, The Netherlands

5. Rheumatology Department, Charité – University Medicine, Berlin, Germany

6. Department of Medicine, University of Alberta, Edmonton, Alberta, Canada

7. Department of Internal Medicine and Rheumatology, Klinikum Bielefeld, Bielefeld, Germany

8. Department of Internal Medicine, Ghent University Hospital, Ghent, Belgium

9. Rheumazentrum Ruhrgebiet, Herne, Germany

10. Swedish Medical Center, University of Washington, Seattle, WA

11. Altoona Center for Clinical Research, Duncansville, PA

12. Division of Rheumatology, University of Utah School of Medicine, Salt Lake City, UT, USA

13. UCB Pharma, Slough, UK

14. UCB Pharma, Monheim, Germany

15. UCB Pharma, Raleigh, NC

16. Division of Arthritis and Rheumatic Diseases, Oregon Health & Science University, Portland, OR, USA

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/56/9/1498/24245819/kex174.pdf

Reference32 articles.

1. Evaluation of diagnostic criteria for ankylosing spondylitis;Linden;Arthritis Rheum,1984

2. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection;Rudwaleit;Ann Rheum Dis,2009

3. Non-radiographic axial spondyloarthritis and ankylosing spondylitis: what are the similarities and differences?;Baraliakos;RMD Open,2015

4. Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis;Stolwijk;Ann Rheum Dis,2015

5. Spondyloarthritis is associated with poor function and physical health-related quality of life;Singh;J Rheumatol,2009

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of sex and gender on axSpA diagnosis and outcomes;Best Practice & Research Clinical Rheumatology;2023-09

2. Comparative Pharmacoeconomic Effectiveness of Interleukin-17 Inhibitors for the Treatment of Ankylosing Spondylitis;Doklady Biochemistry and Biophysics;2023-08

3. A review of patient-reported outcome measures used in uveitis;Survey of Ophthalmology;2023-03

4. Long-Term Safety and Efficacy of Ixekizumab in Patients With Axial Spondyloarthritis: 3-year Data From the COAST Program;The Journal of Rheumatology;2023-02-15

5. Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus;Annals of the Rheumatic Diseases;2023-01-23